Skip to main content
Fig. 3 | Diagnostic Pathology

Fig. 3

From: Expression of FAM83H and ZNF16 are associated with shorter survival of patients with gallbladder carcinoma

Fig. 3

Survival analysis according to co-expression patterns of nuclear FAM83H and nuclear ZNF16 in gallbladder carcinoma patients. a Survival analysis for overall survival and relapse-free survival in four subgroups of gallbladder carcinoma according to the expression of nuclear FAM83H (nFAM83H) and nuclear ZNF16 (nZNF16): nFAM83H−/nZNF16−, nFAM83H−/nZNF16+, nFAM83H+/nZNF16−, and nFAM83H+/nZNF16+ subgroups. b Survival analysis for overall survival and relapse-free survival in two groups of gallbladder carcinomas: [nFAM83H−/nZNF16−] and [nFAM83H−/nZNF16+, nFAM83H+/nZNF16− or nFAM83H+/nZNF16+] subgroups

Back to article page

Diagnostic Pathology

ISSN: 1746-1596

Contact us